[Efficacy, safety of high intensity focused ultrasound (HIFU-ExAblate)]
Escalona Lopez S, Reza Goyanes M, Blasco Amaro JA
Record ID 32011001560
Spanish
Authors' objectives:
Authors' recommendations:
ExAblate® is a new technology used in the treatment of uterine fibroids with some more experiences mainly in breast cancer. There is not enough evidence level about the ef!cacy.Additional studies focusing on posttreatment evaluation and for evaluating the ef!cacy and effectiveness in comparative with other methods are needed with a high number of patients and long-term follow-up.
Details
Project Status:
Completed
Year Published:
2008
URL for published report:
http://www.madrid.org/cs/Satellite?blobcol=urldata&blobheader=application/pdf&blobkey=id&blobtable=MungoBlobs&blobwhere=1220368042285&ssbinary=true
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Ultrasonic Therapy
- Leiomyoma
- Uterine Neoplasms
Contact
Organisation Name:
Unidad de Evaluacion de Tecnologias Sanitarias
Contact Address:
Elena Andradas Aragones, Unidad de Evaluacion de Tecnologias Sanitarias, Agencia Lain Entralgo, C/ Gran Via, 27, 8a, ES-28013 Madrid, Spain. Tel: +34 91 3089418; Fax: +34 91 3089458;
Contact Name:
elena.andradas@salud.madrid.org
Contact Email:
elena.andradas@salud.madrid.org
Copyright:
<p>Unidad de Evaluacion de Tecnologias Sanitarias (UETS)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.